Frontlight ResearchEarly access
CompletedNo phase
Human Perception of Odors and Odor Blockers
Key facts
- Who runs it
- Tim McClintock
- Where
- Lexington, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 27 people enrolled
- Started
- 5 Apr 2024
- Ended
- 15 May 2025
- Type of study
- Interventional
- Treatments tested
- Odorants
- Record updated
- 23 July 2026
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Smoker
Who cannot take part
- Non Smoker
- Self reported inability to smell or taste
Where in United States
- University of KentuckyLexington, United States
About the trial
What the trial wants to find out
The goal of this clinical trial is to determine whether blockers of perception of key odorants in cigarette smoke have any utility in smoking cessation. The main question it aims to answer is:
Read full original descriptionShow less
• Can odor blockers be used to suppress perception of the intensity of cigarette smoke in ways that reduce the ability of the odor of cigarette smoke to increase the urge to smoke.
Participants will be asked to smell up to 20 odor samples per session and report on odor pleasantness and desire to smoke.
The group in the trial
- Participants that SmokeTreatment being tested
Each smoker is asked to smell up to 20 samples per session. Samples include controls (clean air, irrelevant odor), blocking odors, cigarette smoke, and cigarette smoke mixed with blocking odors or irrelevant odors.
Treatment: Odorants
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 23 July 2026